For the first time in more than two decades, a completely new form of antipsychotic medication will be available in the U.S. following an approval Thursday by the Food and Drug Administration. While ...
The U.S. government plans to release a preliminary list of 101 generic drugs, available for no more than $2, to Medicare recipients. The initiative, expected to start in January 2027, aims to make ...
MONCYTE Health diagnostics, developing proprietary technology to optimize treatment and prevention of cardiovascular disease, has closed a EUR 1 million seed round to fund its go-to-market strategy.